Elizondo David R 4

4 · ATS MEDICAL INC · Filed Jul 1, 2010

Form 4

Period: 2010-06-30

VP-Research & Development

Transactions

Exercise/Conversion
Restricted Stock Units
2010-06-30−40,000→ 0 total
From: 2009-07-30Exp: 2013-07-30→ Common Stock (40,000 underlying)
Exercise/Conversion
Common Stock
2010-06-30+40,000→ 123,426.709 total
Sale
Common Stock
2010-06-30$3.96/sh−13,125$51,984→ 110,301.709 total

Holdings

Restricted Stock Units
From: 2010-03-15Exp: 2014-03-05→ Common Stock (52,852 underlying)
52,852
Restricted Stock Units
From: 2011-03-01Exp: 2015-03-01→ Common Stock (15,000 underlying)
15,000
Restricted Stock Units
From: 2008-03-15Exp: 2012-03-15→ Common Stock (17,674 underlying)
17,674
Restricted Stock Units
From: 2009-03-15Exp: 2013-03-15→ Common Stock (52,577 underlying)
52,577
Restricted Stock Units
From: 2007-09-29Exp: 2011-09-29→ Common Stock (20,000 underlying)
20,000
Restricted Stock Units
From: 2011-03-01Exp: 2015-03-01→ Common Stock (53,410 underlying)
53,410

Footnotes (6)

[F1]Includes shares acquired under the Employee Stock Purchase Plan as of June 30, 2010.
[F2]The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 10, 2009.
[F3]1 unit for 1 share of Common Stock.
[F4]Vests in cumulative annual installments of 20% beginning the date shown.
[F5]Represents last vesting date.
[F6]Vests in 20% annual cumulative installments starting on the date shown; in the second year remaining vesting is subject to acceleration if certain performance criteria are met.

Documents

1 file